Stock MVIR B MEDIVIR AB
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Medivir AB

Equities

MVIR B

SE0020181014

Delayed Nasdaq Stockholm
Other stock markets
 05:43:19 2024-05-14 am EDT 		5-day change 1st Jan Change
2.96 SEK +0.34% Intraday chart for Medivir AB -1.33% +3.86%
May. 07 Medivir Aktiebolag Approves Board Appointments CI
Apr. 30 Transcript : Medivir AB, Q1 2024 Earnings Call, Apr 30, 2024

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medivir Says Phase 2a Study of Fostrox With Lenvima Has 17% Overall Response Rate, 72% Disease Control Rate
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MVIR B Stock
  4. News Medivir AB
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW